Sydney Morning Herald Meda AB slid 8.1 per cent in Stockholm after the maker of the Dymista allergy medicine said it's not in talks to merge with another pharmaceutical...
Bloomberg ... AHL fund lost about 8.7 percent in May and UBS AG analysts cut their rating on the stock. Meda AB (MEDAA) slid 8.1 percent in Stockholm after the maker o...
Patch.com Job description: Will supervise and coordinate the daily activities of process operators in a production facility that manufactures active pharmaceutical ingredients or intermediate medical devices. Qualifications: Bachelor's degree is required ...
The Pharma Letter With less R&D investment than the pharmaceutical industry, this sector is able to bring more products into clinical phase trials. The fact that the industry achieved a level of maturity in 2011 was confirmed in 2012 by the continuation of external ... 更多 »
The Pharma Letter The US Food and Drug Administration has approved US biotech firm Celgene's (Nasdaq: CELG) supplemental New Drug Application for Revlimid (lenalidomide) for the treatment of patients with mantle cell lymphoma (MCL) whose disease has relapsed or ... as ... 更多 »
Medical Xpress Such an added benefit cannot be derived from the dossier, however, as the drug manufacturer did not submit any relevant data: it did not cite any studies that directly compared ingenol mebutate with diclofenac/hyaluronic acid gel, and the method chosen ... 更多 »
NASDAQ (press release) ACETO Corporation, incorporated in 1947, is a global leader in the marketing, sale and distribution of products for Human Health (finished dosage ...
MarketWatch (press release) "We are seeing a great deal of interest in our CHOZN� Platform in Asia as numerous pharmaceutical companies in the region are looking to enter this market," said Dr. Kevin Kayser, Director of the CHOZN� Platform for SAFC. "Going ... Its rich portfolio ...
PR Newswire (press release) More than 100 leading life sciences and pharmaceutical companies already rely on NextDocs solutions including Astra Zeneca, McKesson, Sandoz, Sanofi and the National Cancer Center in Japan. ... discovery and analytical studies; a leading consulting ... and more »
